Last reviewed · How we verify
prevention of tuberculosis disease progression in tuberculin skin test or interferon gamma release assay positive individuals
Approved treatments
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- prevention of tuberculosis disease progression in tuberculin skin test or interferon gamma release assay positive individuals patent landscape — cliff calendar, originator estates, attackable patents
- prevention of tuberculosis disease progression in tuberculin skin test or interferon gamma release assay positive individuals treatment landscape brief
- prevention of tuberculosis disease progression in tuberculin skin test or interferon gamma release assay positive individuals treatment updates RSS
Related
- Treatment landscape: prevention of tuberculosis disease progression in tuberculin skin test or interferon gamma release assay positive individuals patent cliff · prevention of tuberculosis disease progression in tuberculin skin test or interferon gamma release assay positive individuals CI report
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing